Severe disseminated toxoplasmosis after unrelated bone marrow transplantation: a case report.

1. De Renzo A, Pezzullo L, D'Arco A, et al. A five drug regimen (VEBEP) followed by involved field radiotherapy in the treatment of Hodgkin's disease [abstract]. Blood 1998; 92(Suppl. 1):235b (abs. 4009). 2. Flowers MED, Sullivan KM, Martin P, et al. G-CSF stimulated donor peripheral blood infusions as immunotherapy in patients with hematologic malignancies relapsing after allogeneic transplantation [abstract]. Blood 1995; 86:564a. 3. Selleri C, Raiola A, De Rosa G, et al. CD34+enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major AB0-incompatible bone marrow transplantation. Bone Marrow Transplant 1998; 22:605-7. 4. Schmitz N, Gratwohl A, Goldman JM. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 17:471-7. 5. Kolb HJ. Management of relapse. In: Blood and Marrow Transplantation; EBMT handbook 1998, p. 16980. 6. Russell LA, Jacobsen N, Heilmann C, Simonsen AC, Christensen LD, Vindelov LL. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients. Bone Marrow Transplant 1996, 18:4114.